Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04764123Unknown

Typical and Atypical AVNRT High-resolution Mapping

Role: lead

NCT01158716Not ApplicableCompleted

Remote Ischemic Preconditioning in ad Hoc Percutaneous Coronary Interventions

Role: lead

NCT00671905Not ApplicableCompleted

Circumferential Versus Ganglionated Plexi Ablation for Atrial Fibrillation (AF)

Role: lead

NCT00749281Completed

Neutrophil Gelatinase-associated Lipocalin Concentration in Coronary Artery Disease

Role: lead

NCT00738556Not ApplicableCompleted

Spot Drug-Eluting Stenting for Long Coronary Stenoses

Role: lead

All 5 trials loaded